BRITTANY MARTIN: Open Payments
NPI 1376195578 · TRAFALGAR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 28 payments from 14 companies in 2025. Trend: 2023 $331 · 2024 $794 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 3 | $61 |
| Exact Sciences Corporation | 3 | $58 |
| Amgen Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Corium, LLC | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, OTEZLA, TRELEGY ELLIPTA, Azstarys, The Cologuard Plus Collection Kit, MOUNJARO, LEQVIO, JARDIANCE.
Industry payments across IN — which companies pay providers there.
